
Stock Club
Could Eli Lilly (NYSE:LLY) Become the First $10 Trillion Stock?
Emmet turns this week's episode into a guessing game, teasing five clues before revealing a 150-year-old company that's become one of the most important businesses in the world: Eli Lilly (NYSE:LLY). Founded in Indianapolis in 1876, Lilly introduced the world's first commercially available insulin in 1923, pioneered recombinant DNA medicine with Humulin in 1982, and brought the world Prozac in 1986. Today it's a $1.1 trillion company, and both Bill Mann and Porter Stansberry have separately pitched it as a candidate to become the world's first $10 trillion business. Emmet breaks down why: Mounjaro and Zepbound drove Q2 2026 revenue up 48 percent to $23 billion, the obesity drug market may address a global population the World Health Organization estimates at 890 million adults, and Lilly's new oral pill Foundayo (orforglipron) just added a convenient alternative to injections. He also covers the experimental triple-agonist drug Retatrutide, Lilly's $5.6 billion Houston manufacturing buildout, and the math behind what a true ten-x over 20 years would actually require. This months following Prophet, spotlighting this month's standout addition to the model portfolio, Ross Stores. Stocks Mentioned Eli Lilly and Company (NYSE:LLY) Ross Stores, Inc. (NASDAQ:ROST) At MyWallSt, we believe great investing is about patience, discipline, and owning outstanding businesses. Our team researches global stocks, publishes transparent performance, and helps investors build long-term wealth without hype or guesswork. Horizon is our long-term buy-and-hold service, while Prophet is a five-minutes-a-month system that has trounced the average market returns over 17 years. #MyWallSt #StockClub #EliLilly #LLY #GLP1 #WeightLossDrugs #TrillionDollarStock #Pharma #StockPicks

